project id: TCGA-SARC; case submitter id: TCGA-UE-A6QT; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.94; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.33; age at index: 50; days to birth: -18516; ethnicity: not hispanic or latino; gender: female; race: asian; vital status: Alive; year of birth: 1963; age at diagnosis: 18516; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 402.0; icd 10 code: C49.0; last known disease status: not reported; morphology: 8854/3; primary diagnosis: Pleomorphic liposarcoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of head, face, and neck; synchronous malignancy: No; tissue or organ of origin: Connective, subcutaneous and other soft tissues of head, face, and neck; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 107; days to sample procurement: 0; initial weight: 850.0; portion submitter id: TCGA-UE-A6QT-01A-12; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 100.0;